Analyst Consensus ?
ConsensusBuy43 ratings
Bullish2455.8%
Neutral1739.5%
Bearish24.7%
Host Hotels & Resorts, Inc. · HST · FY2026 Q1 · Calendar Q2 2026
Host Hotels Beats Q1 Estimates, Raises 2026 RevPAR Guidance on Strong Leisure Demand
Host Hotels & Resorts delivered a strong Q1 2026, with adjusted EBITDA of $543 million (up 5.6% year-over-year) and adjusted FFO per share of $0.67, beating consensus estimates by 87%. Revenue of $1.65 billion exceeded consensus by approximately 3%. RevPAR grew 4.6%, driven by rate growth and out-of-room spend at Florida, Phoenix, and San Francisco resorts. The company raised its 2026 comparable hotel RevPAR guidance to 3%-4.5% growth (from 2%-4% previously) and declared a $0.72 per share special dividend funded by proceeds from the sale of two Four Seasons properties. The transformational renovation program is more than 80% complete, delivering a 9-point RevPAR index gain on 21 stabilized assets, and is expected to generate approximately 60% of total hotel EBITDA in 2026. Capital is being returned through share repurchases and dividends while a $545-$655 million capex plan supports…
Reported After market closeNASDAQReal Estate
$17.18B market cap
100quality score
Company context
Snapshot as of publicationHost Hotels & Resorts, Inc., a distinguished member of the S&P 500 index, stands as the world's foremost lodging real estate investment trust (REIT) and a leading proprietor of luxury and upper-upscale hotel properties. The company boasts an extensive portfolio comprising roughly 46,100 rooms distributed among 74 locations across the United States and five international sites. Beyond these owned assets, it also holds non-controlling stakes in seven joint ventures—six domestically and one internationally. The firm's operational approach is characterized by a stringent capital allocation methodology and robust asset management tactics. It collaborates with a broad array of esteemed hospitality brands, including Marriott, Ritz-Carlton, Westin, Sheraton, W, St. Regis, The Luxury Collection, Hyatt, Fairmont, Hilton, Swissôtel, ibis, and Novotel, in addition to various independent hotel labels.
Earnings scorecard
Reported versus consensus
Reported EPS
$0.67
Consensus $0
EPS surprise
+87.4%
Reported versus consensus
Reported revenue
$1.65B
Consensus $1.59B
Revenue surprise
+3.2%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$25.09Previous close
$17Low
$21.82Average
$27High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | In Line | In Line | Maintain | Jul 28, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 23, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 21, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 21, 2026 |
| Ladenburg Thalmann | Buy | Buy | Maintain | Jun 10, 2026 |
| UBS | Neutral | Neutral | Maintain | Jun 2, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 26, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | May 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 12, 2026 |
| Citigroup | Buy | Buy | Maintain | May 12, 2026 |
| Compass Point | Buy | Neutral | Upgrade | Nov 7, 2025 |
| Stifel | Buy | Buy | Maintain | Jul 31, 2025 |
| Jefferies | Hold | Buy | Downgrade | Apr 9, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Feb 18, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 12, 2024 |
| Baird | Neutral | Neutral | Maintain | Aug 5, 2024 |
| Wedbush | Outperform | Outperform | Maintain | May 30, 2024 |
| B of A Securities | Buy | Underperform | Upgrade | Jan 8, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 25, 2022 |
| Goldman Sachs | Neutral | Sell | Upgrade | Dec 15, 2021 |
| Argus Research | Buy | Hold | Upgrade | Sep 10, 2021 |
| Capital One | Overweight | Equal Weight | Upgrade | Jun 18, 2021 |
| BMO Capital | Outperform | Market Perform | Upgrade | Oct 13, 2020 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 8, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Apr 29, 2020 |
| BTIG | Buy | Neutral | Upgrade | Apr 24, 2020 |
| Citi | Neutral | Neutral | Maintain | Nov 19, 2019 |
| Capital One Financial | Overweight | Overweight | Maintain | Jun 25, 2019 |
| Wolfe Research | Underperform | Peer Perform | Downgrade | Mar 13, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 3, 2018 |
| BTIG Research | Buy | Neutral | Upgrade | Dec 4, 2017 |
| Boenning & Scattergood | Outperform | Neutral | Upgrade | Aug 24, 2017 |
| Nomura | Neutral | Buy | Downgrade | Oct 25, 2016 |
| Credit Suisse | Neutral | Neutral | Maintain | Mar 23, 2016 |
| JMP Securities | Market Perform | Outperform | Downgrade | Jan 11, 2016 |
| Canaccord Genuity | Hold | Hold | Maintain | Jul 13, 2015 |
| Bank of America | Underperform | Buy | Downgrade | Jan 16, 2015 |
| MLV & Co. | Hold | Buy | Downgrade | Jan 15, 2015 |
| FBR Capital | Outperform | Market Perform | Upgrade | Oct 16, 2014 |
| McNicoll Lewis Vlak | Buy | Buy | Maintain | Aug 5, 2013 |
| ISI Group | Buy | Neutral | Upgrade | Jun 3, 2013 |
| Evercore Partners | Overweight | Overweight | Maintain | May 29, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $25.09. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $26 | $24.5 | +3.6% | Jul 23, 2026 |
| Argus Research | Marie Ferguson | $27 | $24.9 | +7.6% | Jun 17, 2026 |
| BMO Capital | Analyst unavailable | $27 | $24.78 | +7.6% | Jun 12, 2026 |
| Raymond James | Analyst unavailable | $27 | $24.62 | +7.6% | Jun 8, 2026 |
| Stifel Nicolaus | Simon Yarmak | $26.25 | $24.45 | +4.6% | Jun 4, 2026 |
| UBS | Analyst unavailable | $23 | $23.42 | -8.3% | Jun 2, 2026 |
| Barclays | Analyst unavailable | $23 | $22.98 | -8.3% | Jun 1, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $23 | $21.76 | -8.3% | May 13, 2026 |
| Stifel Nicolaus | Simon Yarmak | $23 | $21.68 | -8.3% | May 7, 2026 |
| Stifel Nicolaus | Analyst unavailable | $22 | $20.26 | -12.3% | Feb 19, 2026 |
| Morgan Stanley | Stephen Grambling | $18 | $18.47 | -28.3% | Jan 16, 2026 |
| Robert W. Baird | Analyst unavailable | $20 | $18.44 | -20.3% | Jan 12, 2026 |
| UBS | Analyst unavailable | $21 | $18.21 | -16.3% | Jan 9, 2026 |
| Barclays | Richard Hightower | $19 | $18.12 | -24.3% | Jan 6, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $19 | $17.02 | -24.3% | Oct 1, 2025 |
| UBS | Robin Farley | $18 | $17.17 | -28.3% | Sep 22, 2025 |
| Truist Financial | Analyst unavailable | $17 | $14.69 | -32.2% | Mar 21, 2025 |
| Compass Point | Analyst unavailable | $18 | $16.32 | -28.3% | Mar 10, 2025 |
| Compass Point | Floris van Dijkum | $22 | $17.99 | -12.3% | Oct 17, 2024 |
| Truist Financial | Patrick Scholes | $20 | $17.37 | -20.3% | Sep 4, 2024 |
| Morgan Stanley | Stephen Grambling | $17 | $16.58 | -32.2% | Aug 21, 2024 |
| Evercore ISI | Duane Pfennigwerth | $21 | $16.05 | -16.3% | Aug 13, 2024 |
| Truist Financial | Patrick Scholes | $23 | $17.76 | -8.3% | May 30, 2024 |
| Barclays | Anthony Powell | $24 | $17.79 | -4.3% | May 30, 2024 |
| UBS | Robin Farley | $20 | $18.59 | -20.3% | Apr 19, 2024 |
| Oppenheimer | Tyler Batory | $21 | $21.07 | -16.3% | Mar 5, 2024 |
| HSBC | Meredith Jensen | $21 | $19.64 | -16.3% | Jan 19, 2024 |
| Evercore ISI | Analyst unavailable | $23 | $15.64 | -8.3% | Jul 11, 2022 |
| Barclays | Analyst unavailable | $22 | $15.47 | -12.3% | Jul 7, 2022 |
| Raymond James | Analyst unavailable | $23 | $20.43 | -8.3% | Jun 2, 2022 |
| Truist Financial | Analyst unavailable | $21 | $19.67 | -16.3% | Jun 1, 2022 |
| Deutsche Bank | Analyst unavailable | $26 | $20.01 | +3.6% | May 6, 2022 |
| Morgan Stanley | Analyst unavailable | $23 | $19.85 | -8.3% | May 6, 2022 |
| Morgan Stanley | Analyst unavailable | $22 | $20.32 | -12.3% | May 2, 2022 |
| BTIG | James Sullivan | $19 | $17.01 | -24.3% | Jan 21, 2022 |
| Evercore ISI | Richard Hightower | $22 | $17.67 | -12.3% | Jan 18, 2022 |
| Morgan Stanley | Thomas Allen | $20 | $17.67 | -20.3% | Jan 18, 2022 |
| Goldman Sachs | Stephen Grambling | $18 | $16.04 | -28.3% | Dec 14, 2021 |
| Stifel Nicolaus | Simon Yarmak | $21 | $18.35 | -16.3% | Nov 8, 2021 |
| Argus Research | Angus Kelleher-Ferguson | $20 | $15.96 | -20.3% | Sep 10, 2021 |
| Capital One Financial | Neil Malkin | $20.5 | $17.77 | -18.3% | Jun 17, 2021 |
Track every rating change on HST the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-0.0%
Event window
SPY move
-0.3%
Same window
Abnormal move
+0.3%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
+13.6%
Up to 20 sessions
HSTSPY benchmark
Follow HST with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
The 2026 comparable hotel RevPAR guidance was raised from 2%-4% (issued in Q4 2025) to 3%-4.5% (Q1 2026). Capex guidance increased from $525-$625 million to $545-$655 million. The Transformational Capital Program passed 80% completion, with 21 stabilized assets now showing a 9-point RevPAR index gain versus 8.7 points reported in Q4 2025. A $0.72 per share special dividend was declared, funded by proceeds from the Four Seasons resort sales disclosed in the prior quarter. The bullish score increased from 82 to 85, and the capex outlook shifted from stable to increasing.
Guidance delta
2026 comparable hotel RevPAR growth guidance raised from 2%-4% to 3%-4.5%. Capex guidance increased from $525-$625 million to $545-$655 million. Guidance sentiment moved from maintained (Q4 2025) to raised (Q1 2026).
Key takeaways
- Q1 2026 exceeded expectations with adjusted EBITDA of $543 million (up 5.6%) and adjusted FFO of $0.67 per share, beating consensus by 87%.
- RevPAR grew 4.6% year-over-year, driven by rate growth and out-of-room spend at Florida, Phoenix, and San Francisco resorts.
- Full-year 2026 comparable hotel RevPAR guidance raised to 3%-4.5% growth from 2%-4% previously.
- A $0.72 per share special dividend was declared, funded by proceeds from the sale of Four Seasons Resort Orlando and Jackson Hole.
- The transformational renovation program is over 80% complete and is expected to generate approximately 60% of total hotel EBITDA in 2026.
Management priorities
- Complete remaining Hyatt and Marriott transformational renovations across 34 hotels.
- Finalize condo development at Four Seasons Orlando, with approximately $15 million in 2026 spend.
- Maintain dividend policy including regular and special dividends.
- Continue share repurchase program as capital permits.
- Remain opportunistic on acquisitions while prioritizing free cash flow generation.
Sources
- Earnings call transcript and parsed analysis · 2026-06-01T20:23:50.312434+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-31T07:13:30.690746+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T07:13:30.688610+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.